Susan Rowell to Antifibrinolytic Agents
This is a "connection" page, showing publications Susan Rowell has written about Antifibrinolytic Agents.
Connection Strength
4.175
-
The effects of timing of prehospital tranexamic acid on outcomes after traumatic brain injury: Subanalysis of a randomized controlled trial. J Trauma Acute Care Surg. 2023 01 01; 94(1):86-92.
Score: 0.856
-
Viscoelastic Testing in Traumatic Brain Injury: Key Research Insights. Transfus Med Rev. 2021 10; 35(4):108-112.
Score: 0.796
-
Effect of Out-of-Hospital Tranexamic Acid vs Placebo on 6-Month Functional Neurologic Outcomes in Patients With Moderate or Severe Traumatic Brain Injury. JAMA. 2020 09 08; 324(10):961-974.
Score: 0.743
-
Early Tranexamic Acid Administration After Traumatic Brain Injury Is Associated With Reduced Syndecan-1 and Angiopoietin-2 in Patients With Traumatic Intracranial Hemorrhage. J Head Trauma Rehabil. 2020 Sep/Oct; 35(5):317-323.
Score: 0.742
-
Tranexamic Acid, Mortality, and Intracranial Hemorrhage Type in Moderate or Severe Traumatic Brain Injury. JAMA Surg. 2023 Nov 01; 158(11):1222-1224.
Score: 0.231
-
Association of fibrinolysis phenotype with patient outcomes following traumatic brain injury. J Trauma Acute Care Surg. 2024 Mar 01; 96(3):482-486.
Score: 0.229
-
Tranexamic acid is not inferior to placebo with respect to adverse events in suspected traumatic brain injury patients not in shock with a normal head computed tomography scan: A retrospective study of a randomized trial. J Trauma Acute Care Surg. 2022 07 01; 93(1):98-105.
Score: 0.207
-
Tranexamic acid administration in the field does not affect admission thromboelastography after traumatic brain injury. J Trauma Acute Care Surg. 2020 11; 89(5):900-907.
Score: 0.188
-
Blood-based biomarkers for prediction of intracranial hemorrhage and outcome in patients with moderate or severe traumatic brain injury. J Trauma Acute Care Surg. 2020 07; 89(1):80-86.
Score: 0.183